An Innovative Controlled Ovarian Hyperstimulation (COH) Protocol That Combines Large Oocyte Availability and Physiologic Estrogenic Environment for Good Prognosis In Vitro Fertilization and Embryo Transfer (IVF-ET) Patients
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 May 2018
At a glance
- Drugs Cetrorelix (Primary) ; Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Acronyms NATOS
- 27 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Jun 2019.
- 16 Mar 2018 Planned primary completion date changed from 1 Nov 2018 to 1 Jun 2019.